Advertisement
Actualités Forex
Air Products Investing About $500 Mln To Build Green Hydrogen Production Facility In New York
Industrial gases company Air Products and Chemicals, Inc. (APD) announced Thursday plans to invest approximately $500 million to build, own and operate a 35 metric ton per day facility to produce green liquid hydrogen at a greenfield site in Massena, New York, as well as liquid hydrogen distribution and dispensing operations. The commercial operation of this facility is targeted to begin in 2026-2027.
RTTNews |
il y a 959
Blackstone Real Estate Acquires Bluerock Residential Growth In $3.6 Bln All-cash Deal
Blackstone, Inc. (BX) announced Thursday that affiliates of Blackstone Real Estate have completed the previously announced acquisition of Bluerock Residential Growth REIT, Inc. for $24.25 per share in an all-cash transaction valued at $3.6 billion.
RTTNews
|
il y a 959
WPP Acquires Passport Brand Design For Undisclosed Terms
WPP plc (WPP) announced Thursday the acquisition of Passport Brand Design, a leading brand design agency based in Southern California.
RTTNews
|
il y a 959
U.S. Weekly Jobless Claims Rebound More Than Expected
As the closely watched monthly jobs report looms, the Labor Department released a separate report on Thursday showing first-time claims for U.S. unemployment benefits rebounded by more than expected in the week ended October 1st.
RTTNews
|
il y a 959
U.S. Dollar Higher On Inflation, Fed Tightening Concerns
The U.S. dollar climbed against its major counterparts in the European session on Thursday, as a spike in oil prices intensified concerns over inflation and an aggressive monetary policy tightening by the Federal Reserve.
RTTNews
|
il y a 959
Medical Properties To Sell Connecticut Hospitals To Prospect Medical Holdings
Medical Properties Trust, Inc. (MPW) announced Thursday that it has entered into definitive agreements for the sale of three Connecticut hospitals to Prospect Medical Holdings, the current lessee.
RTTNews
|
il y a 959
Evofem Biosciences Says Vaginal Contraceptive Gel Phexxi Approved In Nigeria
Evofem Biosciences, Inc. (EVFM) announced Thursday that its hormone-free contraceptive vaginal gel Phexxi has been approved by the Nigerian Regulatory Agency NAFDAC (National Agency for Food and Drug Administration and Control). This is the first regulatory approval outside the U.S.
RTTNews
|
il y a 959
more news
German Factory Orders Worse Than Expected
Germany's factory orders declined more than expected in August on weak domestic and foreign demand reinforcing fears of a recession, official data showed Thursday. Manufacturing new orders decreased 2.4 percent month-on-month in August, reversing a revised 1.9 percent rise in July, Destatis reported. Economists had forecast a moderate 0.7 percent drop in August.
RTTNews
|
il y a 959
Apax Partners To Sell Majority Interest In Boasso Global To KKR For Undisclosed Terms
Funds advised by Apax Partners LLP and global investment firm KKR & Co. (KKR) announced Thursday the signing of a definitive agreement under which the Apax Funds will sell their majority interest in Boasso Global, Inc. to KKR.
RTTNews
|
il y a 959
U.S. Weekly Jobless Claims Climb To 219,000
As the closely watched monthly jobs report looms, the Labor Department released a separate report on Thursday showing first-time claims for U.S. unemployment benefits rebounded by more than expected in the week ended October 1st.
RTTNews
|
il y a 959
Peloton To Slash Another 500 Jobs: Reports
Fitness equipment maker Peloton Interactive, Inc. (PTON) is reportedly planning to cut about 500 jobs or 12 percent of its remaining workforce. This will be the company's fourth round of layoffs this year as it struggles to return to profit.
RTTNews
|
il y a 959
Bay Street Likely To Open On Weak Note
Canadian shares look headed for a weak start on Thursday, tracking weakness in European markets and lower crude oil prices.
RTTNews
|
il y a 959
Annovis Bio Says FDA Authorizes Phase 2/3 Trial For Buntanetap In Alzheimer's Disease
Annovis Bio, Inc. (ANVS), a late-stage clinical drug platform company, announced Thursday that the U.S. Food and Drug Administration (FDA) has authorized the Phase 2/3 clinical study of buntanetap in moderate Alzheimer's Disease (AD).
RTTNews
|
il y a 959
Stay up to date!
Add Actualités to your browser
Add To Chrome
